Post-IPO Equity - Akero Therapeutics
Investment Firm
Overview
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Announced Date
Jun 16, 2022
Funding Type
Post Ipo Equity
Highlights
N/A
Location
N/A
Social
N/A
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
Akero Therapeutics raised $25000000 on 2022-06-16 in Post-IPO Equity
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 16, 2022 | 1 | - | 100.0M | |
| Sep 13, 2022 | - | 200.0M | ||
| May 15, 2023 | - | 124.2M | ||
| Mar 05, 2024 | - | 366.9M |
Recent Activity
There is no recent news or activity for this profile.